Scott McKeown recently joined Wolf Greenfield's Washington, DC office as a shareholder in the Post-Grant Proceedings Practice. Scott focuses his practice on high-stakes matter before the US Patent.
USPTO proposed a variety of changes to the pre-institution requirements and briefing process for post-grant proceedings intended to provide clarity and curb abusive litigation tactics. The deadline for submitting comments and suggestions related to these rules is June 20, 2023.
Blaine Hackman focuses his Wolf Greenfield practice on post-grant proceedings before the US Patent and Trademark Office (USPTO), and related patent litigation, prosecution.
Attorney Jonathan Roses is a shareholder in Wolf Greenfield's Pharmaceutical Practice Group. He works with life sciences companies in a variety of areas, including small molecule pharmaceuticals.
Among the more than 2,000 firms and entities that appeared in proceedings at the Patent Trial and Appeal Board between the fall of 2012 and August 2021, women attorneys made up just 12% of all attorney appearances, according to a new report from the PTAB Bar Association.